Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00237172
Status:
COMPLETED
Last Update Posted:
2012-05-01
First Post:
2005-10-09
Brief Title:
Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors Extension Study
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis